Dr. Gibril Ndow is the head of the Hepatitis Research Group at the MRC Unit The Gambia at LSHTM and an honorary research fellow at Imperial College London.
Dr. Ndow coordinates the PROLIFICA (Prevention of Liver Fibrosis and Cancer in Africa, www.prolifica.africa) research program in The Gambia and Senegal and leads several ancillary hepatitis B studies at the MRC Gambia.
Dr. Ndow’s research investigates the mechanisms underlying disease progression and surface antigen loss in Africans with chronic hepatitis B infection, and aims to identify new biomarkers of disease severity and targets for curative treatment.
